Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?-Reference-Cited by-同舟云学术

Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?

Published:2023-08-25 Issue:12 Volume:44 Page:4525-4529
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Lauletta Antonio^ORCID,De Carolis Lanfranco,Teresi Valentina,Fionda Laura,Leonardi Luca,Ceccanti Marco,Costanzo Rocco,Rossini Elena,Tufano Laura,Merlonghi Gioia,Morino Stefania,Garibaldi Matteo

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10072-023-07035-w.pdf

Reference11 articles.

1. Liang L, Zhang Y-M, Chen H, Ye L-F, Li S-S, Lu X et al (2020) Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis. Eur J Dermatol. https://doi.org/10.1684/ejd.2020.3750

2. Alhatou MI, Sladky JT, Bagasra O, Glass JD (2004) Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology. J Mol Histol 35:615–619. https://doi.org/10.1007/s10735-004-2194-6

3. Garibaldi M, Fionda L, Vanoli F, Leonardi L, Loreti S, Bucci E et al (2020) Muscle involvement in myasthenia gravis: expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients. Autoimmun Rev 19:102498. https://doi.org/10.1016/j.autrev.2020.102498

4. Kim H, Dill S, O’Brien M, Vian L, Li X, Manukyan M et al (2021) Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis. Ann Rheum Dis 80:406–408. https://doi.org/10.1136/annrheumdis-2020-218690

5. Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7:86. https://doi.org/10.1038/s41572-021-00321-x